Literature DB >> 8307046

Ceftriaxone versus penicillin G in the short-term treatment of meningococcal meningitis in adults.

K Marhoum el Filali1, M Noun, A Chakib, M Zahraoui, H Himmich.   

Abstract

Short-term treatment with ceftriaxone 2 g once daily for two days (group 1) was compared to treatment with a standard regimen of penicillin G (group 2) for six days in adults with meningococcal meningitis. Thirty-six patients were allocated in a randomized fashion to a treatment group: 16 to group 1 and 20 to group 2. The clinical and microbiological results were comparable in the two treatment groups. In both groups cultures of cerebrospinal fluid were sterile after 24 hours. One patient in each group died. In group 1 one case of fulminant meningococcemia and one case of brain abscess required further antibiotic treatment. It is concluded that short-term treatment with ceftriaxone is feasible but patients with severe forms of meningitis would not be eligible for treatment with this regimen, and careful follow-up of the patients receiving ceftriaxone is necessary.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8307046     DOI: 10.1007/BF02098465

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

Review 1.  New aspects of prevention and therapy of meningitis.

Authors:  S L Kaplan
Journal:  Infect Dis Clin North Am       Date:  1992-03       Impact factor: 5.982

2.  [Shortened antibiotic therapy of meningococcal meningitis: 5-day administration of ceftriaxone].

Authors:  J C Auvergnat; J Y Le Tallec; B Marchou; P Massip; J P Carrière; M Armengaud
Journal:  Pathol Biol (Paris)       Date:  1988-06

3.  Ceftriaxone in the treatment of bacterial meningitis in adults.

Authors:  I Zavala; E Barrera; A Nava
Journal:  Chemotherapy       Date:  1988       Impact factor: 2.544

4.  Short course single daily ceftriaxone monotherapy for acute bacterial meningitis in children: results of a Swiss multicenter study. Part I: Clinical results.

Authors:  E Martin; P Hohl; T Guggi; F H Kayser; M Fernex
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

5.  Pharmacokinetics of ceftriaxone in neonates and infants with meningitis.

Authors:  E Martin; J R Koup; U Paravicini; K Stoeckel
Journal:  J Pediatr       Date:  1984-09       Impact factor: 4.406

6.  Ceftriaxone in the treatment of bacterial meningitis in children.

Authors:  V Prado; J Cohen; A Banfi; J Cordero; W Ledermann; J Cofré; L Reyes
Journal:  Chemotherapy       Date:  1986       Impact factor: 2.544

7.  [Bacteriological, pharmacological and clinical comparison between amoxycillin and ceftriaxone in the treatment of 300 purulent meningitis ].

Authors:  M Cadoz; F Denis; T Guerma; M Prince-David; I Diop Mar
Journal:  Pathol Biol (Paris)       Date:  1982-06

8.  Treatment of childhood bacterial meningitis with ceftriaxone once daily: open, prospective, randomized, comparative study of short-course versus standard-length therapy.

Authors:  J Kavaliotis; S G Manios; A Kansouzidou; V Danielidis
Journal:  Chemotherapy       Date:  1989       Impact factor: 2.544

9.  Four days of penicillin therapy for meningococcal meningitis.

Authors:  P F Viladrich; R Pallares; J Ariza; G Rufi; F Gudiol
Journal:  Arch Intern Med       Date:  1986-12

10.  Treatment of bacterial meningitis with once daily ceftriaxone therapy.

Authors:  W M Dankner; J D Connor; M Sawyer; R Straube; S A Spector
Journal:  J Antimicrob Chemother       Date:  1988-05       Impact factor: 5.790

View more
  4 in total

1.  Use of ceftriaxone during epidemics in patients with suspected meningococcal meningitis.

Authors:  Allan R Tunkel
Journal:  Curr Infect Dis Rep       Date:  2006-06       Impact factor: 3.725

Review 2.  Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis.

Authors:  K Prasad; A Kumar; P K Gupta; T Singhal
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 3.  Pre-admission antibiotics for suspected cases of meningococcal disease.

Authors:  Thambu D Sudarsanam; Priscilla Rupali; Prathap Tharyan; Ooriapadickal Cherian Abraham; Kurien Thomas
Journal:  Cochrane Database Syst Rev       Date:  2017-06-14

Review 4.  Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.

Authors:  Harriet M Lamb; Douglas Ormrod; Lesley J Scott; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.